|
|
|
|
|
|
|
|
|
|
"Severe myelotoxicity was reported in 6 of 12 patients."
Conclusion:
Conclusion:
Combining either 800 or 400 mg per day pazopanib with standard carboplatin/paclitaxel chemotherapy is not a feasible treatment option.
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.